Cancer Cell International

Article	Citations
The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C	373
Correction to: Short‑term starvation synergistically enhances cytotoxicity of Niraparib via Akt/mTOR signaling pathway in ovarian cancer therapy	231
Retraction Note: Silencing of TRIM11 suppresses the tumorigenicity of chordoma cells through improving the activity of PHLPP1/AKT	216
Identification and validation of ARF6 for a potential prognostic biomarker of acute myeloid leukemia	216
Amino acid-based risk stratification model improves prognostic precision in diffuse large B-cell lymphoma	189
Curcumin attenuates smoking and drinking activated NF-κB/IL-6 inflammatory signaling axis in cervical cancer	167
PMA exerts anti-leukemia effect in Ph+ ALL through activating PKC δ and its down-stream molecules	159
miR-196a-5p promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting LIFR	144
A multi-analyte liquid biopsy approach for nonseminomatous testicular germ cell tumors: combining cfDNA and N-glycan analysis in blood and seminal plasma	131
Venetoclax synergizes with Wnt/β-catenin inhibitor C-82 in acute myeloid leukemia by increasing the degradation of Mcl-1 protein	125
Alantolactone enhances the sensitivity of melanoma to MAPK pathway inhibitors by targeting inhibition of STAT3 activation and down-regulating stem cell markers	120
Hepatocellular carcinoma drug resistance models	110
TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer	106
Integrating bioinformatics and experimental validation to unveil disulfidptosis-related lncRNAs as prognostic biomarker and therapeutic target in hepatocellular carcinoma	103
MicroRNAome profiling of breast cancer unveils hsa-miR-5683 as a tumor suppressor microRNA predicting favorable clinical outcome	97
Transcription factor MYB regulates glycolysis to promote the transfer and malignant progression of gastric cancer through the SSBP2/ISL1 axis	90
Iron metabolism: backfire of cancer cell stemness and therapeutic modalities	83
Platinum-based drugs induce phenotypic alterations in nucleoli and Cajal bodies in prostate cancer cells	81
Revealing a novel Decorin-expressing tumor stromal subset in hepatocellular carcinoma via integrative analysis single-cell RNA sequencing	78
Construction of a CCL20-centered circadian-signature based prognostic model in cervical cancer	76
Mortalin promotes the evolution of androgen-independent prostate cancer through Wnt/β-catenin signaling pathway	75
KCNN4 may weaken anti-tumor immune response via raising Tregs and diminishing resting mast cells in clear cell renal cell carcinoma	75
Evaluation of functional magnetic resonance APT and DKI imaging for breast cancer	75
Metformin regulates the proliferation and motility of melanoma cells by modulating the LINC00094/miR-1270 axis	72
Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics	72

PTH2R is related to cell proliferation and migration in ovarian cancer: a multi-omics analysis of bioinformatics and experiments	70
New models for MPNST: establishment and comprehensive characterization of two tumor cell lines	70
Human amniotic epithelial cells exert anti-cancer effects through secretion of immunomodulatory small extracellular vesicles (sEV)	68
Imaging the metabolic reprograming of fatty acid synthesis pathway enables new diagnostic and therapeutic opportunity for breast cancer	67
Molecular mechanisms of microRNA-216a during tumor progression	65
Deciphering the prognostic features of bladder cancer through gemcitabine resistance and immune-related gene analysis and identifying potential small molecular drug PIK-75	63
Syntaxin6 contributes to hepatocellular carcinoma tumorigenesis via enhancing STAT3 phosphorylation	60
Potential role of P4HB in the tumor microenvironment and its clinical prognostic value: a comprehensive pan-cancer analysis and experimental validation with a focus on KIRC	60
SLC25A17 inhibits autophagy to promote triple-negative breast cancer tumorigenesis by ROS-mediated JAK2/STAT3 signaling pathway	60
Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression	58
Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies	58
OTUD3 inhibits breast cancer cell metastasis by regulating TGF-β pathway through deubiquitinating SMAD7	57
Cuproptosis: a promising new target for breast cancer therapy	56
Smad2/3/4 complex could undergo liquid liquid phase separation and induce apoptosis through TAT in hepatocellular carcinoma	54
ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors	53
Melanoma biology and treatment: a review of novel regulated cell death-based approaches	53
SULF1 regulates malignant progression of colorectal cancer by modulating ARSH via FAK/PI3K/AKT/mTOR signaling	51
miR-199b-3p contributes to acquired resistance to cetuximab in colorectal cancer by targeting CRIM1 via Wnt/β-catenin signaling	50
TAGLN: a stiffness-driven prognostic biomarker for metastatic colorectal cancer	49
Molecular and phenotypic characterization of 5-FU resistant colorectal cancer cells: toward enrichment of cancer stem cells	49
Deciphering 17-β-hydroxysteroid dehydrogenase 4: from molecular insights to cancer therapeutics	48
Muscone abrogates breast cancer progression through tumor angiogenic suppression via VEGF/PI3K/Akt/MAPK signaling pathways	48
HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives	47
Unraveling the role of the solute carrier family in hepatocellular carcinoma: mechanisms and therapeutic prospects	47
Anterior gradient 2 induces resistance to sorafenib via endoplasmic reticulum stress regulation in hepatocellular carcinoma	47
Retraction Note: circRNA hsa_circRNA_0000069 promotes the proliferation, migration and invasion of cervical cancer through miR-873-5p/TUSC3 axis	46
TSTA3 overexpression promotes malignant characteristics in LUSC by regulating LAMP2-mediated autophagy and tumor microenvironment	45
Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia	45
[email protected] nanoparticle for regulates the expression of GSDMB and targeted therapy of tumor	45
Identification of CD4_Naive cells related gene FMO4 as a positive regulator of the poor prognosis of septic CRC patients	44
Oncogenic roles of the lncRNA LINC00460 in human cancers	44
Correction: Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia	44
Development and validation of a risk prediction model for overall survival in patients with nasopharyngeal carcinoma: a prospective cohort study in China	44
ZNF655 promotes tumor growth and chemoresistance by targeting MAFF-CCND1 axis in ovarian cancer	43
STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment	43
Comprehensive analysis of ESCRT transcriptome-associated signatures and identification of the regulatory role of LMO7-AS1 in osteosarcoma	43
C6orf15 promotes liver metastasis via WNT/β-catenin signalling in colorectal cancer	43
Circular RNA EPB41 expression predicts unfavorable prognoses in NSCLC by regulating miR-486-3p/eIF5A axis-mediated stemness	42
The circRNA hsa-circ-0013561 regulates head and neck squamous cell carcinoma development via the miR-7-5p/PDK3 axis	42
Pomegranate juice and punicalagin-mediated chemoprevention of hepatocellular carcinogenesis via regulating miR-21 and NF-κB-p65 in a rat model	41
Hsa-miR-423-5p selectively loaded in hypoxic exosomes reduces the sensitivity of normoxic hepatocellular carcinoma to sorafenib via autophagy	40
Identifying disulfidptosis subtypes in hepatocellular carcinoma through machine learning and preliminary exploration of its connection with immunotherapy	40
Deapioplatycodin D inhibits glioblastoma cell proliferation by inducing BNIP3L-mediated incomplete mitophagy	40
Anoikis-related signature predicts prognosis and characterizes immune landscape of ovarian cancer	40
Microglia-mediated drug substance transfer promotes chemoresistance in brain tumors: insights from an in vitro co-culture model using GCV/Tk prodrug system	40
Activation of the chemokine receptor 3 pathway leads to a better response to immune checkpoint inhibitors in patients with metastatic urothelial carcinoma	39
Co-delivery of camptothecin and SH3RF3-AS1 SiRNA for glioma synergistic therapy	38
Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesis	38
Inhibition of autophagy induced by tetrandrine promotes the accumulation of reactive oxygen species and sensitizes efficacy of tetrandrine in pancreatic cancer	38
Multiomic traits reveal that critical irinotecan-related core regulator FSTL3 promotes CRC progression and affects ferroptosis	37

Nuclear-activating miRNAs: unveiling the intricacies of subcellular miRNA function and regulation in cancer and immunity disease	37
Development and validation of a novel 3-gene prognostic model for pancreatic adenocarcinoma based on ferroptosis-related genes	37
A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma	36
The function and mechanism of PSMD14 in promoting progression and resistance to anlotinib in osteosarcoma	36
USP24 promotes hepatocellular carcinoma progression by deubiquitinating and stabilizing YAP1	36
LncRNA PGM5-AS1 inhibits non-small cell lung cancer progression by targeting miRNA-423-5p/SLIT2 axis	35
Machine learning-based prognostic model of lactylation-related genes for predicting prognosis and immune infiltration in patients with lung adenocarcinoma	35
SGLT2 inhibition restrains thyroid cancer growth via G1/S phase transition arrest and apoptosis mediated by DNA damage response signaling pathways	35
Development and validation of sensitive BCR::ABL1 fusion gene quantitation using next-generation sequencing	35
CAR-T cell combination therapy: the next revolution in cancer treatment	35
Eukaryotic translation initiation factor 3 subunit B promotes head and neck cancer via CEBPB translation	34
Spatial and single-cell analyses uncover links between ALKBH1 and tumor-associated macrophages in gastric cancer	34
The role of platelets in tumor immune evasion and metastasis: mechanisms and therapeutic implications	34
Migration and invasion of cancer stem cells are prevented by low-intensity pulsed ultrasound therapy	33
Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer	33
Specificity protein 1 initiates epithelial-mesenchymal transition of circulating tumor cells to inhibit metastasis in prostate cancer	33
Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes	33
High anti-tumor activity of a novel alpha-fetoprotein-maytansinoid conjugate targeting alpha-fetoprotein receptors in colorectal cancer xenograft model	33
G-CSF upregulates the expression of aquaporin-9 through CEBPB to enhance the cytotoxic activity of arsenic trioxide to acute myeloid leukemia cells	33
Predicting survival of persons with newly-diagnosed multiple myeloma	32
Retraction Note to: Degradation of long non-coding RNA-CIR decelerates proliferation, invasion and migration, but promotes apoptosis of osteosarcoma cells	32
Retraction Note: LncRNA HAND2-AS1 exerts anti-oncogenic effects on bladder cancer via restoration of RARB as a sponge of microRNA-146	32
Integrated bioinformatics analysis of SEMA3C in tongue squamous cell carcinoma using machine-learning strategies	32
PPP2R1B abolishes colorectal cancer liver metastasis and sensitizes Oxaliplatin by inhibiting MAPK/ERK signaling pathway	32
Circular RNA circPTPRF promotes the progression of GBM via sponging miR-1208 to up-regulate YY1	32
Complicated role of ALKBH5 in gastrointestinal cancer: an updated review	32
Retraction Note: MicroRNA-93-5p promotes epithelial-mesenchymal transition in gastric cancer by repressing tumor suppressor AHNAK expression	31
Broussoflavonol B induces S-phase arrest and apoptosis in pancreatic cancer cells by modulating the cell cycle checkpoint through inhibition of the AURKA/PLK1 pathway	31
Characterization of pyruvate metabolism and citric acid cycle patterns predicts response to immunotherapeutic and ferroptosis in gastric cancer	31
Whole exome sequencing identifies novel variants of PIK3CA and validation of hotspot mutation by droplet digital PCR in breast cancer among Indian population	30
MeCP2 confers 5-fluorouracil resistance in gastric cancer via upregulating the NOX4/PKM2 pathway	30
Molecular analysis of androgen receptor splice variant AR-V3 reveals eminent ambiguity regarding activity and clinical utility	30
Development of a prognostic pyroptosis-related gene signature for head and neck squamous cell carcinoma patient	30
Evaluation of plasma cell sorting methods in multiple myeloma patients: flow cytometry versus magnetic beads	30
Disulfidptosis in pediatric AML: a multi-omics approach to risk stratification and potential therapeutic strategy	30
NORAD-sponged miR-378c alleviates malignant behaviors of stomach adenocarcinoma via targeting NRP1	30
Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential	30
Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation	30
Establishment of disulfidptosis-related LncRNA signature as biomarkers in colon adenocarcinoma	30
Construction of anti-tumor immune gene signature for HNSCC and identification of 4'-Hydroxywogonin as a potential immunotherapy combination drug	30
Adipocytes promote metastasis of breast cancer by attenuating the FOXO1 effects and regulating copper homeostasis	30
SLC9A9 links tumor immune infiltration to therapeutic response in colorectal cancer with emphasis on mismatch repair proficient subtype	30
Identification of proteomic markers for prediction of the response to 5-Fluorouracil based neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients	29
The impact of gut bacteria producing long chain homologs of vitamin K2 on colorectal carcinogenesis	29
CTCF-activated FUCA1 functions as a tumor suppressor by promoting autophagy flux and serum α-L-fucosidase serves as a potential biomarker for prognosis in ccRCC	29
Enhancing therapeutic efficacy in luminal androgen receptor triple-negative breast cancer: exploring chidamide and enzalutamide as a promising combination strategy	29
Plasma tRNA-derived small RNAs signature as a predictive and prognostic biomarker in lung adenocarcinoma	29
E3 ubiquitin ligase HECW2: a promising target for tumour therapy	29
Ferroptosis: insight into the treatment of hepatocellular carcinoma	28
The role of LncRNAs in tumor immunotherapy	28
Diverse activity of miR-150 in Tumor development: shedding light on the potential mechanisms	28
The upregulation of VGF enhances the progression of oral squamous carcinoma	28
A novel immune-related lncRNA pair signature for prognostic prediction and immune response evaluation in gastric cancer: a bioinformatics and biological validation study	28
A synthesized olean-28,13β-lactam targets YTHDF1-GLS1 axis to induce ROS-dependent metabolic crisis and cell death in pancreatic adenocarcinoma	28
DUSP5 regulated by YTHDF1-mediated m6A modification promotes epithelial-mesenchymal transition and EGFR-TKI resistance via the TGF-β/Smad signaling pathway in lung adenocarcinoma	28
Correction: The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer‑cause or consequences? A systematic review	27
Involvement of abnormal dystroglycan expression and matriglycan levels in cancer pathogenesis	27
Interaction of AURKA with TRIM28 revives dormant LSCC cells via Akt signaling pathway to promote LSCC metastasis	27
Role of the long non-coding RNAs in regulation of Gemcitabine response in tumor cells	27
FGFR1 is a potential therapeutic target in neuroblastoma	27
Correction: TEAD4 overexpression promotes epithelial-mesenchymal transition and associates with aggressiveness and adverse prognosis in head neck squamous cell carcinoma	27
Luteolin: a flavonoid with a multifaceted anticancer potential	27
Niosome-loaded silibinin and methotrexate for synergistic breast cancer combination chemotherapy: in silico and in vitro study	27
Comprehensive analysis, diagnosis, prognosis, and cordycepin (CD) regulations for GSDME expressions in pan-cancers	26
Exosomal biomarkers and immune checkpoint inhibitors: advancements and future prospects	26
Identification of fatty acids synthesis and metabolism-related gene signature and prediction of prognostic model in hepatocellular carcinoma	26
Molecular evidence reveals thyrotropin intervention enhances the risk of developing radioiodine-refractory differentiated thyroid carcinoma	26
Retraction Note: Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma	26
Targeting the USP7-CDK1 axis suppresses estrogen receptor-positive breast cancer progression	26
Salivary genetic biomarkers of lung cancer: a systematic review and meta-analysis of the diagnostic accuracy	26
Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade	26
Retraction Note: Knockdown of circRNA_0007534 suppresses the tumorigenesis of cervical cancer via miR-206/GREM1 axis	26
Sestrin2 reduces cancer stemness via Wnt/β-catenin signaling in colorectal cancer	26
Mechanism study of oleanolic acid derivative, K73-03, inducing cell apoptosis in hepatocellular carcinoma	25
RGS20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition of the PKA-Hippo signaling pathway	25
Does rAj-Tspin, a novel peptide from A. japonicus, exert antihepatocellular carcinoma effects via the ITGB1/ZYX/FAK/AKT signaling pathway?	25
Marine natural product Methyl mycophenolate inhibits gastric cancer growth through regulating p53 and the downstream pathways	25
Identification and validation of the high expression of pseudogene TCAM1P in cervical cancer via integrated bioinformatics analysis	25
Molecular mechanisms of inhibitor of growth (ING) family members in health and malignancy	25
The anti-tumor effects of AZD4547 on ovarian cancer cells: differential responses based on c-Met and FGF19/FGFR4 expression	25

circ_0061265 competitively binds to microRNA-885-3p to promote the development of gastric cancer by upregulating AURKA expression	25
Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia	25
Real world analysis of the efficacy and safety of eribulin compared to utidelone in combination with capecitabine for the treatment of metastatic breast cancer	25
Identification and validation of a prognostic model based on three TLS-Related genes in oral squamous cell carcinoma	24
Association of whole grain food consumption with lung cancer risk: a prospective cohort study	24
High LGALS3 expression induced by HCP5/hsa-miR-27b-3p correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma	24
MiR-129-5p exerts Wnt signaling-dependent tumor-suppressive functions in hepatocellular carcinoma by directly targeting hepatoma-derived growth factor HDGF	24
PIBF1 (p.R405Q) germline variant identified in cancer susceptibility family impairs protein stability and function	24
ARF6 promotes hepatocellular carcinoma proliferation through activating STAT3 signaling	23
STAT3-mediated upregulation of LINC00520 contributed to temozolomide chemoresistance in glioblastoma by interacting with RNA-binding protein LIN28B	23
NSC777201 exhibits anticancer activity against colorectal cancer cells by inducing multiple types of cell death	23
DAB2IP predicts treatment response and prognosis of ESCC patients and modulates its radiosensitivity through enhancing IR-induced activation of the ASK1-JNK pathway	23
LncRNA SNHG1: role in tumorigenesis of multiple human cancers	23
Novel insights into the interaction between IGF2BPs and ncRNAs in cancers	23
Senescence-related circRNA circHIF-1α is associated with pancreatic cancer progression	22
Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation	22
NCAPG facilitates colorectal cancer cell proliferation, migration, invasion and epithelial–mesenchymal transition by activating the Wnt/β-catenin signaling pathway	22
MiR-155 deficiency and hypoxia results in metabolism switch in the leukemic B-cells	22
Correction to: Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes	22
Biological roles of SLC16A1-AS1 lncRNA and its clinical impacts in tumors	22
The expression of pro-prion, a transmembrane isoform of the prion protein, leads to the constitutive activation of the canonical Wnt/β-catenin pathway to sustain the stem-like phenotype of human gliob	22
Correction to: SIRT6/HIF-1α axis promotes papillary thyroid cancer progression by inducing epithelial–mesenchymal transition	22
Domperidone inhibits cell proliferation via targeting MEK and CDK4 in esophageal squamous cell carcinoma	22
Cannabidiol in pancreatic ductal adenocarcinoma: preclinical evidence, molecular mechanisms, and translational challenges	22
Combinatorial phenethyl isothiocyanate and withaferin A targets multiple epigenetics pathways to inhibit MCF-7 and MDA-MB-231 human breast cancer cells	22
A review on the role of mir-16-5p in the carcinogenesis	22
Win or loss? Combination therapy does improve the oncolytic virus therapy to pancreatic cancer	22
A serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinoma	21
Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1	21
Sensitization of hepatocellular carcinoma cells to HDACi is regulated through hsa-miR-342-5p/CFL1	21
An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer	21
ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients	21
Impact of β3-adrenergic receptor agonist on tumor progression and metastasis in renal cell carcinoma models	21
Oncogenic LINC00698 suppresses apoptosis of melanoma stem cells to promote tumorigenesis via LINC00698-miR-3132-TCF7/hnRNPM axis	21
Disruption of DMD gene leads to altered calcium homeostasis and metabolic shift impacting gastric Cancer cell proliferation and migration	21
Flavonoids target different molecules of autophagic and metastatic pathways in cancer cells	21
Single cell sequencing deciphering the heterogeneous landscape of blastic plasmacytoid dendritic cell neoplasm with novel MYB-ZFAT fusion gene	21
Analysis of genetic biomarkers, polymorphisms in ADME-related genes and their impact on pharmacotherapy for prostate cancer	21
Efficacy of MAGE-A4 long peptide as a universal immunoprevention cancer vaccine	20
Role of m6A RNA methylation regulators in pancreatic cancer: interactions and potential implications	20
LncRNA SPINT1-AS1 enhances the Warburg effect and promotes the progression of osteosarcoma via the miR-135b-5p/PGAM1 axis	20
A comprehensive review about the utilization of immune checkpoint inhibitors and combination therapy in hepatocellular carcinoma: an updated review	20
LTCONS_00014107-miR-29b-2-3p-GPR37 axis promotes heat stimulation induced esophageal carcinogenesis	20
HOXC6 impacts epithelial-mesenchymal transition and the immune microenvironment through gene transcription in gliomas	20
Very long-chain fatty acids accumulate in breast cancer tissue and serum	20
Tumour cells can escape antiproliferative pressure by interferon-β through immunoediting of interferon receptor expression	20
Circulating IFNγ-associated protein signatures predict response to neoadjuvant immunotherapy in patients with stage III melanoma	20
A review of exercise-induced epigenetic modifications in prostate tissue: implications for gene expression and tumor progression in prostate cancer	20
Mithramycin targets head and neck cancer stem cells by inhibiting Sp1 and UFMylation	20
The effect of the polycystic ovary syndrome and hypothyroidism on the risk of fibrocystic breast changes: a meta-analysis	20
UCHL3: a crucial deubiquitinase in DNA damage repair and tumor progression	20
Single-cell sequencing in bladder cancer: new insights from tumor cell diversity to individualized treatment strategies	20
Targeting cuproptosis for treatment and prognostic assessment in endometrial cancer	20
Unveiling the oncogenic role of SLC25A13: a multi-omics pan-cancer analysis reveals its impact on glioma progression	19
Methylomics and cancer: the current state of methylation profiling and marker development for clinical care	19
Emerging roles for lncRNA-NEAT1 in colorectal cancer	19
Identification and validation of a ferroptosis-related gene to predict survival outcomes and the immune microenvironment in lung adenocarcinoma	19
Transforming bone cancer treatment: a comprehensive review of green-synthesized metal nanoparticles	19
Gastric cancer cell-originated small extracellular vesicle induces metabolic reprogramming of BM-MSCs through ERK-PPARγ-CPT1A signaling to potentiate lymphatic metastasis	19
MDM2: current research status and prospects of tumor treatment	19
The role of m6A modification in non-small cell lung cancer: functional insights and impact on therapy resistance	19
Environmental interpretation of the impact of vehicle emissions on prostate cancer progression	19
Exploring the role of pyroptosis in shaping the tumor microenvironment of colorectal cancer by bulk and single-cell RNA sequencing	19
Evaluation of X-ray and carbon-ion beam irradiation with chemotherapy for the treatment of cervical adenocarcinoma cells in 2D and 3D cultures	19
Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma	19
Targeting oral tumor microenvironment for effective therapy	19
Prognostic evaluation and experimental validation of cuproptosis-related hub genes identified through weighted gene co-expression network analysis in uveal melanoma	19
Comparison of mucin-1 in human breast cancer and canine mammary gland tumor: a review study	19
MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways	19
Green-synthesized MnFe₂O₄/GO nanocomposites: structural characterization, cytotoxicity, and potential for targeted cervical cancer therapy	19
Insights into the E2F target genes in breast cancer: associations of pathway genes with prognosis and immune cell filtration based on in silico and ex vivo analyses	19
Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review	19
MSI2 regulates NLK-mediated EMT and PI3K/AKT/mTOR pathway to promote pancreatic cancer progression	19
Are chemical compounds in medical mushrooms potent against colorectal cancer carcinogenesis and antimicrobial growth?	19
Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway	18
Breast cancer scoring based on a multiplexed profiling of soluble and cell-associated (immune) markers facilitates the prediction of pembrolizumab therapy	18
Expression of HECTD2 predicts peritoneal metastasis of gastric cancer and reconstructs immune microenvironment	18
Correction: Efficacy and prognostic analysis of venetoclax combined with hypomethylating agents for induction therapy in acute myeloid leukemia: a multi-center real-world study on indication-specific	18
ZBTB7A, a miR-144-3p targeted gene, accelerates bladder cancer progression via downregulating HIC1 expression	18
Analysis of the associations between DNA methylation and clinical features reveals the potential oncogenic effect of CFAP52 in esophageal squamous cell cancer	18
Regulatory mechanisms and clinical implications of PIWI-interacting RNAs (piRNAs) in major digestive tract cancers	18
As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner	18
Correction: Current view of liver cancer cell-of-origin and proposed mechanisms precluding its proper determination	18
Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy	18
Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line derived from a Chinese patient	18
CircITGA7 overexpression suppresses HCC progression via miR-330/BCL11B axis regulation	18
Cardiac Troponin T (TNNT2) plays a potential oncogenic role in colorectal carcinogenesis	18
Comprehensive analysis of KLF family reveals KLF6 as a promising prognostic and immune biomarker in pancreatic ductal adenocarcinoma	18
Characterization of G2/M checkpoint classifier for personalized treatment in uterine corpus endometrial carcinoma	18
Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis	18
Development and validation of a disulfidptosis and disulfide metabolism-related risk index for predicting prognosis in lung adenocarcinoma	18
Construction and validation of acetylation-related gene signatures for immune landscape analysis and prognostication risk prediction in luminal breast cancer	18
Correction: The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies	18
N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma	18
P21-activated kinase 4: a potent oncogene, molecular mechanisms and opportunities for targeted therapy	18